flstandardbreds Chapter 352 A $100 Billion Acquisition?
Chapter 352 A $100 Billion Acquisition?
……
"Yes, I have nothing to do anyway."
"I have so much time every day and I don't know what to do. I might as well do experiments."
"Maybe I'm lucky and have discovered some new medicine, which would be great value for money."
Chen Xuan answered this question casually.
As for drug experiments, he has indeed never stopped.
I do experiments almost every day, and the time spent on experiments is basically the longest. It is like this every day.
Moreover, the fourth stage of the system was also progressing very well. Even though the activation process was more difficult than the first three stages combined, he was still conquering it bit by bit.
As long as the fourth stage is successfully activated, he will be able to obtain new drug results. This process is equivalent to developing new drugs.
But when other researchers are doing experiments, they have a general direction for drug development, but he is completely unaware and has no idea what medical results he will get in the future.
"As for what kind of drugs, I can't answer that question for now."
"Whether these projects will succeed is still unknown, so it's pointless to say too much now."
Chen Xuan spoke again.
It wasn't that he wanted to keep it a secret.
But there was nothing he could do, he himself didn't know what formula the system would reward him.
This time is different from usual. You cannot know what the recipe is in advance. Instead, you can only see what the recipe is after the fourth stage activation progress is fully activated.
So even if he didn't want to keep it a secret, he had no way to answer this question, and could only use confidentiality as an excuse.
Not to mention Anna, it was the same even within Antai Pharmaceutical Group. Even Luo Shiyun couldn't have known it in advance.
"I can understand that, but I still admire you so much. You're really amazing."
"Not only are you extremely talented, you're also the most dedicated scientist I've ever met. I've never seen a genius scientist as hardworking as you."
"After achieving so many world-class results, you can still persist in research and development without slacking off for a single day. Of all the people out there, you're the only one I've seen do that."
Anna exclaimed in admiration from the bottom of her heart.
She was indeed very shocked.
Chen Xuan's answer let her know that Antai Pharmaceutical Group had a new drug project and that it might be progressing well.
Although it is still unknown whether the projects he mentioned will be successful, the fact that he has mentioned this at least means that the success rate is not low, and it is very likely that they have already progressed to a very important stage.
This shocked her.
She never thought that the other party was still working tirelessly to develop new drugs.
Moreover, he was talking about these projects, not a single project, which means that Antai Pharmaceutical Group has more than one new drug research and development project. It is very likely that two or even multiple research and development projects are being carried out at the same time.
This is what shocked Anna the most.
She even vaguely felt that Chen Xuan was likely to shock the world again.
His achievements may become world-class medical achievements, and there may be more than one.
Although the possibility is extremely low and almost unrealistic, she always feels that he can do it.
This made her start to look forward to it.
At the same time, Anna also admired Chen Xuan from the bottom of her heart, and this was not just a polite remark.
She has seen many hard-working and talented scientists, but she has only seen Chen Xuan, a talented scientist who can still work so hard and forget about food after achieving so many top results.
After achieving success and fame, especially after obtaining world-class results, many scientists find it difficult to devote all their energy to scientific research. They usually gradually withdraw from the front line, mainly working behind the scenes, or only appearing in key experiments. They rarely devote all their energy to scientific research.
On the one hand, my body can’t take it, and on the other hand, there are too many temptations from the outside world.
After achieving world-class results, life will indeed be subject to various temptations, and very few people can stick to their original aspirations.
Chen Xuan is one of them. Not only can he stick to his original intention, but he can also devote his wholehearted and greatest energy and never stop because of his achievements.
This also made Anna unconsciously develop great respect for him.
"Mr. Chen, have you heard of Elsilan?"
At this time, Anna suddenly asked again.
She looked at Chen Xuan's face, wondering what his answer would be.
"I know. There's been a lot of talk lately about the company Pfizer wants to acquire."
"No matter how ignorant I am, there is no way I haven't heard of this matter, but why did you suddenly mention it?"
Chen Xuan answered casually, not showing much concern about the matter.
In fact, this matter was not very important to him. Elsilan posed no threat to him.
"Yes, Pfizer does want to acquire Elsilan."
"Based on Pfizer's recent investigation, the acquisition is almost certain."
"Also, thanks to this acquisition, Pfizer's stock price has risen significantly recently, as the market is optimistic about Alciran's anti-cancer drug project."
Anna spoke out about this.
She said this now to remind Chen Xuan.
Pfizer will inevitably become a rival to Aetna Pharmaceuticals, especially given the recent relationship between the two, which makes it more likely that they will become enemies.
That's why she specifically reminded him and wanted to know his attitude towards this matter.
However, Chen Xuan's expression remained extremely calm.
My mood is also calm.
The main reason is that he had already ended his short selling on Pfizer, and the profits had long been returned to his wallet, so it didn't matter whether the stock price went up or not. Even if it went up wildly, it had nothing to do with him.
Of course, Pfizer has only confirmed the acquisition and has not officially completed it, but the stock price has risen a lot. It seems that the market is indeed very optimistic about this project.
"Pfizer's acquisition price should be between $80 billion and $100 billion."
"Mr. Chen, do you think this anti-cancer project is worth acquiring? If you were the decision-maker at Pfizer, would you agree to the acquisition?"
Anna asked again, "Or, if you were the head of the Elsilan company, would you sell the anti-cancer drug project for this price?"
She just wanted to know whether this anti-cancer drug project was really that valuable?
A $100 billion acquisition is a relatively rare acquisition, and one that Novartis takes very seriously.
However, she was unable to analyze the benefits and risks of this project for the time being, so she wanted to get some judgment from Chen Xuan.
The latter analysis may not be correct, but it is certainly of great reference value, which is why she asked this question.
This is not just curiosity, but also from a business perspective.
If the project is extremely profitable, Novartis will also consider competing with Pfizer.
"I'm not Pfizer, so I can't judge whether this project is worthwhile."
"After all, I don't really understand this project. Maybe Pfizer has more detailed information to make a judgment."
"But if I were Pfizer and were in charge of this project, I probably wouldn't acquire it. The risk is too great and I don't think it's worth it."
Chen Xuan said with a puzzled expression, "But if I were on the Elsilan side, I would sell this formula without hesitation, the sooner the better, and get the money as much as possible."
Chen Xuan was still extremely surprised by the $100 billion acquisition.
But after thinking about it, I realized that this is an anti-cancer drug project, and it has entered the third phase of clinical trials, and the clinical performance is very ideal.
Analyzing from the information disclosed so far, the return rate of this project will be very high-risk, but it seems to be completely controllable, which naturally leads to such a high value.
A new drug formula.
From before clinical trials to phase I, phase II, and then phase III, the value of each stage is extremely different.
Maybe it is only worth 100 billion US dollars during the first phase of clinical trials, but after the third phase of clinical trials, it may be directly worth 10 billion US dollars. This is normal.
After all, the failure rate at each stage is very high. Being able to persist until the third phase of clinical trials has already proved its great potential, but it may also become worthless.
……